This Week in Plastic Surgery — Jun 19, 2026

Welcome to This Week in Plastic Surgery. This week we're covering 8 notable papers spanning advancements in breast surgery, optimizing patient selection for aesthetic and reconstructive procedures, and a look at the future of our specialty with new techniques and technologies. Let's dive in.

We begin with a focus on optimizing outcomes in breast surgery, with two large evidence syntheses. First, from the Aesthetic Surgery Journal, a systematic review and meta-analysis of over 380,000 patients examines how common breast procedures impact breastfeeding success [4]. For patients considering augmentation, the data is reassuring: no single technique was associated with a significant difference in overall breastfeeding success rates. Similarly, nipple correction methods did not appear to substantially reduce success. The story changes, however, with reduction mammaplasty. The analysis found that breast reduction procedures are associated with a significant decrease in breastfeeding success, and this risk varies considerably by the surgical technique employed. Specifically, classic reduction approaches using horizontal or vertical pedicles were linked to the lowest success rates, while techniques preserving central, superior-lateral, or superomedial pedicles showed much more promising outcomes, with some achieving success rates near one hundred percent. The clinical implication here is clear: counseling must be nuanced, and for patients prioritizing future lactation, the choice of pedicle is paramount. Shifting from functional outcomes to reconstructive planning, a systematic review and meta-analysis in Microsurgery evaluates the best preoperative imaging for perforator flap surgeries, particularly DIEP flaps [5]. Across 32 studies and over 3,000 patients, computed tomography angiography, or CTA, remains the most studied and robust modality, demonstrating high perforator utilization and low complication rates. While alternatives are being explored due to concerns about radiation and cost, this analysis sounds a note of caution. Specifically, using ultrasound alone was associated with the highest rate of complications at over 17 percent. Interestingly, the lowest complication rate, at just under 11 percent, was seen when CTA was combined with ultrasound, suggesting a synergistic benefit from integrating CTA's anatomical precision with the dynamic feedback of an ultrasound exam. While MRA showed the highest perforator utilization, the data is more limited. For now, the evidence supports CTA as the workhorse for DIEP flap planning, and relying on ultrasound alone may increase patient risk.

Next, we turn to a theme of patient factors and their profound impact on surgical decision-making and outcomes, with three papers from Aesthetic Plastic Surgery. First, a prospective study addresses the new and growing cohort of patients seeking body contouring after weight loss from GLP-1 agonists like Ozempic or Wegovy [3]. Researchers compared 38 of these patients to 34 traditional post-bariatric surgery patients. The good news is that both groups achieved significant and comparable improvements in body satisfaction scores at six months. However, the study uncovered a crucial psychological distinction: the GLP-1 cohort reported higher preoperative expectations and demonstrated greater emotional reactivity and dissatisfaction with residual contour irregularities postoperatively. This suggests that while the surgical results are equivalent, the counseling for GLP-1 patients must be tailored to manage these heightened expectations and sensitivities. In another study on risk stratification, investigators used the American College of Surgeons NSQIP database to evaluate the utility of the modified 5-item Frailty Index, or mFI-5, in over 10,000 cosmetic surgery patients [9]. They found that true frailty is rare in this population, with 88 percent having a score of zero. However, the complication rate did increase stepwise with the score, from 3 percent for a score of zero, to 6 percent for a score of one, and 12 percent for a score greater than one. An mFI-5 score over 1 was an independent predictor of complications, readmission, and reoperation. Digging deeper, the index in this population was driven almost entirely by just two components: hypertension and diabetes. The authors conclude that while the mFI-5 does predict risk, in cosmetic surgery it likely functions more as a simple comorbidity score rather than a measure of true physiological frailty. Finally, a large retrospective cohort study of over 190,000 patients explores how a diagnosis of a somatoform disorder, such as body dysmorphic disorder, affects decision-making in post-mastectomy breast reconstruction [10]. After propensity score matching, the analysis found that while a somatoform disorder diagnosis did not deter patients from choosing immediate reconstruction, it was associated with a significantly higher likelihood of undergoing delayed reconstruction. The hazard ratio was 1.59 for delayed autologous and 1.24 for delayed implant-based reconstruction. This suggests that psychological factors, perhaps related to decisional conflict or body image concerns, play a major role in timing. The findings underscore the importance of integrating mental health assessment into preoperative counseling to help facilitate more timely and individualized reconstructive decisions for these patients.

Our final theme explores new frontiers in technique and technology. From Plastic and Reconstructive Surgery, the WAFER trial provides high-quality comparative data on WALANT—or Wide-awake Local Anesthesia No Tourniquet—versus general or regional anesthesia for flexor tendon repair [2]. This multicenter, assessor-blinded randomized controlled trial of 60 patients found that clinical outcomes, including total active motion scores and tendon rupture rates, were similar between the two groups at six months. However, the advantages for WALANT were economic and logistical. Intra-operative costs were 54 percent lower with WALANT, and patients in the WALANT arm returned to work more than twice as fast, at a mean of 3 weeks versus nearly 7 weeks for the general anesthesia group. This trial provides strong evidence that a WALANT approach is not only safe and clinically equivalent, but also offers substantial benefits in cost and productivity. In the realm of basic science, a paper in Aesthetic Plastic Surgery investigates a novel strategy to enhance fat graft survival using PLLA microspheres, the same material used in fillers like Sculptra [8]. In both in-vitro and murine models, the researchers demonstrated that PLLA enhances fat graft volume retention. The proposed mechanism is that PLLA degrades into lactate, which in turn promotes the dedifferentiation of mature adipocytes into more resilient precursor cells and also enhances neovascularization. This provides a compelling scientific rationale for co-transplanting PLLA with adipose tissue to improve the predictability and longevity of fat grafting. And finally, a paper in Nature points toward the future of medical artificial intelligence [1]. Researchers developed MIRA, an autonomous AI agent operating in a simulated electronic health record environment. Unlike simple chatbots, MIRA could perform complex clinical workflows: obtaining patient histories, ordering and interpreting labs and imaging, generating differential diagnoses, and formulating treatment plans, including prescribing medications and scheduling procedures. In simulations using real patient cases, MIRA actually outperformed physicians in diagnostic accuracy and made guideline-concordant decisions. While this is not ready for clinical implementation, it represents a significant step beyond current AI tools and suggests a future where EHR-integrated agents could become powerful decision-support partners for physicians.

If you only have time for one paper this week, make it the WAFER trial comparing WALANT to general anesthesia for flexor tendon repair, published in Plastic and Reconstructive Surgery [2]. As a multicenter randomized controlled trial, it provides the high-level evidence needed to confidently adopt a technique that shows equivalent clinical outcomes but is substantially cheaper and gets patients back to their lives and work more than twice as quickly.

Here are the key takeaways from this week in Plastic Surgery. One: For breast surgery, counsel patients that reduction mammaplasty, particularly with horizontal or vertical pedicles, carries a significant risk to future breastfeeding, whereas augmentation and nipple procedures appear safe [4]. For DIEP flap reconstruction, rely on preoperative CTA, as using ultrasound alone is associated with higher complication rates [5]. Two: When performing body contouring on patients with GLP-1-induced weight loss, be aware that they may have higher expectations and greater sensitivity to minor imperfections compared to post-bariatric patients, requiring tailored preoperative counseling [3]. Three: For flexor tendon repairs, the WAFER trial provides strong evidence to support using WALANT, which offers equivalent clinical outcomes to general anesthesia at a lower cost and with a much faster return to work [2]. Four: In cosmetic surgery patients, the modified 5-item frailty index predicts postoperative complications, but it primarily functions as a marker of comorbidity burden from hypertension and diabetes, not true frailty [9]. Five: Patients with a history of somatoform disorders are significantly more likely to opt for delayed breast reconstruction, highlighting an opportunity for integrated mental health support to aid in surgical decision-making [10].

That's your roundup for This Week in Plastic Surgery. The full transcript and references are available on the episode page in your AudioScholar library. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.

If this weekly briefing is useful, follow the show in your podcast app so new episodes arrive automatically. And for audio briefings on your own clinical questions and papers, visit audioscholar dot C C.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.